19th May 2015 07:54
LONDON (Alliance News) - Biotechnology company PuriCore PLC on Tuesday said it has appointed Alex Martin as its chief executive, effective from after its general meeting on June 18.
He will join the company on June 1 and will work with retiring CEO Michael Ashton to ensure a smooth transition.
Martin is the former chief executive of Affectis Pharmaceuticals AG, the German drug company.
PuriCore shares were untraded Tuesday, having last traded at 29.32 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
PURI.L